Difference between revisions of "Team:Jiangnan/Background"
(Created page with "<html> <link rel="stylesheet" href="https://2018.igem.org/Team:Jiangnan/CSSmaterializecss?action=raw&ctype=text/css"> <style type="text/css"> #home_logo, #sideMenu { di...") |
|||
| (12 intermediate revisions by 2 users not shown) | |||
| Line 88: | Line 88: | ||
<li><a href="https://2018.igem.org/Team:Jiangnan/Entrepreneurship">Gold</a></li> | <li><a href="https://2018.igem.org/Team:Jiangnan/Entrepreneurship">Gold</a></li> | ||
<li class="divider"></li> | <li class="divider"></li> | ||
| − | <li><a href="https://2018.igem.org/Team:Jiangnan/Public_Engagement"> | + | <li><a href="https://2018.igem.org/Team:Jiangnan/Public_Engagement">Public Engagement</a></li> |
<li class="divider"></li> | <li class="divider"></li> | ||
<li><a href="https://2018.igem.org/Team:Jiangnan/Entrepreneurship">Entrepreneurship</a></li> | <li><a href="https://2018.igem.org/Team:Jiangnan/Entrepreneurship">Entrepreneurship</a></li> | ||
| Line 130: | Line 130: | ||
<div style="background-color: #f0ebea;width:100%"> | <div style="background-color: #f0ebea;width:100%"> | ||
| − | <img src="https://static.igem.org/mediawiki/2018/2/29/T--Jiangnan--background_top.png" width="100%" style=" | + | <img src="https://static.igem.org/mediawiki/2018/2/29/T--Jiangnan--background_top.png" width="100%" style="margin-top: -15em;"> |
| − | <h3 style="margin-top: 1em;text-align: center; color: white">Background</h3> | + | <h3 style="position: absolute; top: 1em; z-index: 1;margin-top: 1em;text-align: center; color: white;width: 100%">Background</h3> |
| − | <div class="row " style="margin | + | <div class="row " style="margin: 0 auto;"> |
<div class="col s8 offset-s2"> | <div class="col s8 offset-s2"> | ||
| − | <p>Vaccine has been considered as one of the most cost-effective public health solution which could be used to prevent a large varieties of diseases. However, several factors such as high cost, unstable quality, weak supervision have been considerably limiting the development of the vaccine industry. Jiangnan team is thus motivated to reduce the cost of vaccine production through establishing a suspension cell line with self-owned intellectual for rapid production of a broad spectrum of viruses using synthetic biology approaches.</p> | + | <p>Vaccine has been considered as one of the most cost-effective public health solution which could be used to prevent a large varieties of diseases. However, several factors such as high cost, unstable quality, weak supervision have been considerably limiting the development of the vaccine industry. Jiangnan team is thus motivated to reduce the cost of vaccine production through establishing a suspension cell line with self-owned intellectual for rapid production of a broad spectrum of viruses using synthetic biology approaches.<br/><br/><br/><br/></p> |
</div> | </div> | ||
<div style="text-align: center;"> | <div style="text-align: center;"> | ||
| Line 140: | Line 140: | ||
</div> | </div> | ||
<div class="col s8 offset-s2"> | <div class="col s8 offset-s2"> | ||
| − | <p>We do not have any biosafety issue as we do not work with human viruses but focus on animal vaccine at the current stage which do not impose any risk to the lab or environment.</p> | + | <br/><br/><br/><p>We do not have any biosafety issue as we do not work with human viruses but focus on animal vaccine at the current stage which do not impose any risk to the lab or environment.</p> |
</div> | </div> | ||
<div class="col s8 offset-s2"> | <div class="col s8 offset-s2"> | ||
Latest revision as of 03:02, 18 October 2018
Background
Vaccine has been considered as one of the most cost-effective public health solution which could be used to prevent a large varieties of diseases. However, several factors such as high cost, unstable quality, weak supervision have been considerably limiting the development of the vaccine industry. Jiangnan team is thus motivated to reduce the cost of vaccine production through establishing a suspension cell line with self-owned intellectual for rapid production of a broad spectrum of viruses using synthetic biology approaches.
We do not have any biosafety issue as we do not work with human viruses but focus on animal vaccine at the current stage which do not impose any risk to the lab or environment.
Reference
1. Merten O W. Introduction to animal cell culture technology—past, present and future [J]. Cytotechnology, 2006, 50(1-3): 1.
2. Tapia F, Vázquez-Ramírez D, Genzel Y, et al. Bioreactors for high cell density and continuous multi-stage cultivations: options for process intensification in cell culture-based viral vaccine production [J]. Appl Microbiol Biotechnol, 2016, 100(5): 2121-2132.
3. Vlecken D H W, Pelgrim R P M, Ruminski S, et al. Comparison of initial feasibility of host cell lines for viral vaccine production [J]. Journal of Virological Methods, 2013, 193(1): 28-41.